BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34774657)

  • 1. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
    Kus KJB; Murad F; Smile TD; Chang M; Ashrafzadeh S; Zhou G; Ilori EO; Koyfman SA; Vidimos AT; Schmults CD; Ruiz ES
    J Am Acad Dermatol; 2022 Apr; 86(4):766-773. PubMed ID: 34774657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of lymphovascular invasion in cutaneous squamous cell carcinoma.
    Huang SS; Toon CW; Harish V
    ANZ J Surg; 2023 Nov; 93(11):2727-2735. PubMed ID: 37727039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
    Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
    J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
    Roccuzzo G; Orlando G; Rumore MR; Morrone A; Fruttero E; Caliendo V; Picciotto F; Sciarrillo A; Quaglino P; Cassoni P; Ribero S; Senetta R
    Dermatology; 2024; 240(2):329-336. PubMed ID: 38008073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Lymphovascular Invasion in Oral Cavity Squamous Cell Carcinoma Regional Metastasis and Prognosis.
    Moore AE; Alvi SA; Tarabichi O; Zhu VL; Buchakjian MR
    Ann Otol Rhinol Laryngol; 2024 Mar; 133(3):300-306. PubMed ID: 37927046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
    Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
    Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study.
    Praiss AM; Allison D; Tessier-Cloutier B; Flynn J; Iasonos A; Hoang L; Patrichi A; Terinte C; Pesci A; Mateoiu C; Lastra RR; Puscasiu L; Kiyokawa T; Ali-Fehmi R; Kheil M; Oliva E; Devins KM; Abu-Rustum NR; Soslow RA; Stolnicu S
    Gynecol Oncol; 2023 Sep; 176():147-154. PubMed ID: 37541128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.
    Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J
    J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
    Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
    JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular Invasion Increases the Risk of Nodal and Distant Recurrence in Node-Negative Stage I-IIA Non-Small-Cell Lung Cancer.
    Sung SY; Kwak YK; Lee SW; Jo IY; Park JK; Kim KS; Lee KY; Kim YS
    Oncology; 2018; 95(3):156-162. PubMed ID: 29847825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional study.
    Doi R; Baba N; Kato H; Nakamura M; Matsushita S; Aoki M; Fujimoto N; Kato T; Iino S; Saito S; Yasuda M; Asai J; Ishikawa M; Yatsushiro H; Kawahara Y; Inafuku K; Matsuya T; Araki R; Teramoto Y; Hasegawa M; Nakama T; Nakamura Y
    Exp Dermatol; 2023 Oct; 32(10):1682-1693. PubMed ID: 37395158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management.
    Ruiz ES; Karia PS; Morgan FC; Schmults CD
    J Am Acad Dermatol; 2017 Feb; 76(2):217-225. PubMed ID: 27707594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.